The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Molecular markers of early Parkinson's disease based on gene expression in blood
Open accessAbstract
Parkinson's disease (PD) progresses relentlessly and affects five million people worldwide. Laboratory tests for PD are critically needed for developing treatments designed to slow or prevent progression of the disease. We performed a transcriptome-wide scan in 105 individuals to interrogate the molecular processes perturbed in cellular blood of patients with early-stage PD. The molecular multigene marker here identified is associated with risk of PD in 66 samples of the training set comprising healthy and disease controls [third tertile cross-validated odds ratio of 5.7 ( P for trend 0.005)]. It is further validated in 39 independent test samples [third tertile odds ratio of 5.1 ( P for trend 0.04)]. Insights into disease-linked processes detectable in peripheral blood are offered by 22 unique genes differentially expressed in patients with PD versus healthy individuals. These include the cochaperone ST13 , which stabilizes heat-shock protein 70, a modifier of α-synuclein misfolding and toxicity. ST13 messenger RNA copies are lower in patients with PD (mean ± SE 0.59 ± 0.05) than in controls (0.96 ± 0.09) ( P = 0.002) in two independent populations. Thus, gene expression signals measured in blood can facilitate the development of biomarkers for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126
Self-citationBiomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
An integrative genomics approach to infer causal associations between gene expression and disease
Schadt, E. E., Lamb, J., Yang, X., Zhu, J., Edwards, S., GuhaThakurta, D., Sieberts, S. K., Monks, S., Reitman, M., Zhang, C., et al. (2005) · Nature Genetics · doi:10.1038/ng1589 · Cited by 1,043
Prediction of cancer outcome with microarrays: a multiple random validation strategy
Michiels, S., Koscielny, S., & Hill, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17866-0 · Cited by 1,025
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
Mootha, V. K., Lepage, P., Miller, K., Bunkenborg, J., Reich, M., Hjerrild, M., Delmonte, T., Villeneuve, A., Sladek, R., Xu, F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716699 · Cited by 571
Hsp70 Reduces α-Synuclein Aggregation and Toxicity
Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., & McLean, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400255200 · Cited by 508
Rules of evidence for cancer molecular-marker discovery and validation
Ransohoff, D. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1322 · Cited by 498
Hip, a novel cochaperone involved in the eukaryotic hsc70/hsp40 reaction cycle
Höfeld, J., Minami, Y., & Hartl, F.-U. (1995) · Cell · doi:10.1016/0092-8674(95)90099-3 · Cited by 439
Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme
Kalchman, M. A., Graham, R. K., Xia, G., Koide, H. B., Hodgson, J. G., Graham, K. C., Goldberg, Y. P., Gietz, R. D., Pickart, C. M., & Hayden, M. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19385 · Cited by 361
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
Miller, D. W., Hague, S. M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M. R., & Singleton, A. B. (2004) · Neurology · doi:10.1212/01.wnl.0000127517.33208.f4 · Cited by 356
Shin, Y., Klucken, J., Patterson, C., Hyman, B. T., & McLean, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503326200 · Cited by 329
Loss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316
Self-citationGrünblatt, E., Mandel, S., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246
Offe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 245
Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats
Wang, J.-Y., Wu, J.-N., Cherng, T.-L., Hoffer, B. J., Chen, H.-H., Borlongan, C. V., & Wang, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02450-7 · Cited by 241
Heat Shock Prevents Alpha-synuclein-induced Apoptosis in a Yeast Model of Parkinson's Disease
Flower, T. R., Chesnokova, L. S., Froelich, C. A., Dixon, C., & Witt, S. N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.060 · Cited by 238
Novel Risk Markers and Clinical Practice
Manolio, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038136 · Cited by 174
Sorkina, T., Hoover, B. R., Zahniser, N. R., & Sorkin, A. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00259.x · Cited by 172
MANDEL, S., GRUNBLATT, E., RIEDERER, P., AMARIGLIO, N., HIRSCH, J. J., RECHAVI, G., & YOUDIM, M. B. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00044.x · Cited by 158
Hauser, M. A., Li, Y.-J., Xu, H., Noureddine, M. A., Shao, Y. S., Gullans, S. R., Scherzer, C. R., Jensen, R. V., McLaurin, A. C., Gibson, J. R., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.917 · Cited by 158
Self-citationNagai, Y., Ueno, S., Saeki, Y., Soga, F., Hirano, M., & Yanagihara, T. (1996) · Neurology · doi:10.1212/wnl.46.3.791 · Cited by 150
Modulation of in Vivo HSP70 Chaperone Activity by Hip and Bag-1
Nollen, E. A. A., Kabakov, A. E., Brunsting, J. F., Kanon, B., Höhfeld, J., & Kampinga, H. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009745200 · Cited by 120
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
Scherzer, C. R., Jensen, R. V., Gullans, S. R., & Feany, M. Β. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg265 · Cited by 113
Self-citationDuke, D. C., Moran, L. B., Kalaitzakis, M. E., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · Neurogenetics · doi:10.1007/s10048-006-0033-5 · Cited by 100
Association of Vitamin D Receptor Gene Polymorphism and Parkinson's Disease in Koreans
Kim, J., Kim, Y.-I., Song, C., Yoon, I., Park, J., Choi, Y.-B., Kim, H.-T., & Lee, K.-S. (2005) · Journal of Korean Medical Science · doi:10.3346/jkms.2005.20.3.495 · Cited by 97
Back to the future: the 'old-fashioned' way to new medications for neurodegeneration
Lansbury, P. T. (2004) · Nature Medicine · doi:10.1038/nrn1435 · Cited by 92
Mitochondrial dysfunction in movement disorders
Schulz, J. B., & Beal, M. F. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199408000-00010 · Cited by 92
Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.021 · Cited by 90
Validation of a Telephone Questionnaire for Parkinson’s Disease
Rocca, W. A., Maraganore, D. M., McDonnell, S. K., & Schaid, D. J. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00017-1 · Cited by 87
Children with Type 2 Diabetes: The Risks of Complications
Matthews, D. R., & Wallace, T. M. (2002) · Hormone Research in Paediatrics · doi:10.1159/000053310 · Cited by 45
Yeast genetics targets lipids in Parkinson's disease
Scherzer, C. R., & Feany, M. Β. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.05.005 · Cited by 36
Self-citation
Cited by
The Parkinson Progression Marker Initiative (PPMI)
Marek, K., Jennings, D., Lasch, S., Siderowf, A., Tanner, C., Simuni, T., Coffey, C., Kieburtz, K., Flagg, E., Chowdhury, S., et al. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.005 · Cited by 1,892
Self-citationClassification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang-James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 857
Self-citation
Metadata
- Authors
- Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., Schwarzschild, M. A., Schlossmacher, M. G., Hauser, M. A., Vance, J. M., Sudarsky, L. R., Standaert, D. G., Growdon, J. H., Jensen, R. V., & Gullans, S. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-01-16
- Volume
- 104
- Issue
- 3
- Pages
- 955-960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2157503003
- Cited by
- 512
- References
- 43
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.